291 related articles for article (PubMed ID: 31141251)
1. Exosomes containing ErbB2/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer.
Yoshida K; Tsuda M; Matsumoto R; Semba S; Wang L; Sugino H; Tanino M; Kondo T; Tanabe K; Tanaka S
Cancer Sci; 2019 Jul; 110(7):2119-2132. PubMed ID: 31141251
[TBL] [Abstract][Full Text] [Related]
2. Adaptor protein CRK induces epithelial-mesenchymal transition and metastasis of bladder cancer cells through HGF/c-Met feedback loop.
Matsumoto R; Tsuda M; Wang L; Maishi N; Abe T; Kimura T; Tanino M; Nishihara H; Hida K; Ohba Y; Shinohara N; Nonomura K; Tanaka S
Cancer Sci; 2015 Jun; 106(6):709-717. PubMed ID: 25816892
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Jeppesen DK; Nawrocki A; Jensen SG; Thorsen K; Whitehead B; Howard KA; Dyrskjøt L; Ørntoft TF; Larsen MR; Ostenfeld MS
Proteomics; 2014 Mar; 14(6):699-712. PubMed ID: 24376083
[TBL] [Abstract][Full Text] [Related]
5. Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells.
Huang CS; Ho JY; Chiang JH; Yu CP; Yu DS
Cells; 2020 Jun; 9(6):. PubMed ID: 32517366
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1.
Xue M; Chen W; Xiang A; Wang R; Chen H; Pan J; Pang H; An H; Wang X; Hou H; Li X
Mol Cancer; 2017 Aug; 16(1):143. PubMed ID: 28841829
[TBL] [Abstract][Full Text] [Related]
7. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H
Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020
[TBL] [Abstract][Full Text] [Related]
8. BDNF VAL66MET Polymorphism Elevates the Risk of Bladder Cancer via MiRNA-146b in Micro-Vehicles.
Li C; Zeng X; Liu Z; Li F; Wang K; Wu B
Cell Physiol Biochem; 2018; 45(1):366-377. PubMed ID: 29402794
[TBL] [Abstract][Full Text] [Related]
9. Plasma exosomes stimulate breast cancer metastasis through surface interactions and activation of FAK signaling.
Shtam T; Naryzhny S; Samsonov R; Karasik D; Mizgirev I; Kopylov A; Petrenko E; Zabrodskaya Y; Kamyshinsky R; Nikitin D; Sorokin M; Buzdin A; Gil-Henn H; Malek A
Breast Cancer Res Treat; 2019 Feb; 174(1):129-141. PubMed ID: 30484103
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling.
Zhang J; Wei J; Lu J; Tong Z; Liao B; Yu B; Zheng F; Huang X; Chen Z; Fang Y; Li B; Chen W; Xie D; Luo J
Carcinogenesis; 2013 Oct; 34(10):2401-8. PubMed ID: 23722651
[TBL] [Abstract][Full Text] [Related]
11. Exosomal miR-663b targets Ets2-repressor factor to promote proliferation and the epithelial-mesenchymal transition of bladder cancer cells.
Yin X; Zheng X; Liu M; Wang D; Sun H; Qiu Y; Chen J; Shi B
Cell Biol Int; 2020 Apr; 44(4):958-965. PubMed ID: 31872468
[TBL] [Abstract][Full Text] [Related]
12. ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases.
Spencer KS; Graus-Porta D; Leng J; Hynes NE; Klemke RL
J Cell Biol; 2000 Jan; 148(2):385-97. PubMed ID: 10648571
[TBL] [Abstract][Full Text] [Related]
13. WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity.
Wei X; Wang B; Wu Z; Yang X; Guo Y; Yang Y; Fang Z; Yi C; Zhang L; Fan X; Zhang L; Song D
Cancer Lett; 2023 Mar; 556():216058. PubMed ID: 36627049
[TBL] [Abstract][Full Text] [Related]
14. Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer.
Hu Y; Qi C; Liu X; Zhang C; Gao J; Wu Y; Yang J; Zhao Q; Li J; Wang X; Shen L
Cancer Lett; 2019 Aug; 457():142-150. PubMed ID: 31075288
[TBL] [Abstract][Full Text] [Related]
15. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z
Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771
[TBL] [Abstract][Full Text] [Related]
16. Exosomes from PYCR1 knockdown bone marrow mesenchymal stem inhibits aerobic glycolysis and the growth of bladder cancer cells via regulation of the EGFR/PI3K/AKT pathway.
Li Z; Jiang Y; Liu J; Fu H; Yang Q; Song W; Li Y
Int J Oncol; 2023 Jul; 63(1):. PubMed ID: 37293856
[TBL] [Abstract][Full Text] [Related]
17. Intracellular redox status controls membrane localization of pro- and anti-migratory signaling molecules.
Hempel N; Melendez JA
Redox Biol; 2014; 2():245-50. PubMed ID: 24494199
[TBL] [Abstract][Full Text] [Related]
18. Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells.
Matsumoto R; Tsuda M; Yoshida K; Tanino M; Kimura T; Nishihara H; Abe T; Shinohara N; Nonomura K; Tanaka S
Sci Rep; 2016 Oct; 6():34625. PubMed ID: 27698389
[TBL] [Abstract][Full Text] [Related]
19. Real-time cancer cell tracking by bioluminescence in a preclinical model of human bladder cancer growth and metastasis.
van der Horst G; van Asten JJ; Figdor A; van den Hoogen C; Cheung H; Bevers RF; Pelger RC; van der Pluijm G
Eur Urol; 2011 Aug; 60(2):337-43. PubMed ID: 21616583
[TBL] [Abstract][Full Text] [Related]
20. Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo.
Li Y; Liu H; Lai C; Su Z; Heng B; Gao S
Oncol Rep; 2015 May; 33(5):2319-30. PubMed ID: 25812440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
